« Previous AbstractNon-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results    Next AbstractNon-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD) »

J Breath Res

Title:		Breathomics--exhaled volatile organic compound analysis to detect hepatic encephalopathy: a pilot study
Author(s):		Arasaradnam RP; McFarlane M; Ling K; Wurie S; O'Connell N; Nwokolo CU; Bardhan KD; Skinner J; Savage RS; Covington JA;
Address:		"Department of Gastroenterology, University Hospital Coventry & Warwickshire, Clifford Bridge Road, Coventry CV2 2DX, UK. Clinical Sciences Research Institute, University of Warwick, UK"
Journal Title:		J Breath Res
Year:		2016
Volume:		20160211
Issue:		1
Page Number:		16012 -
DOI:		10.1088/1752-7155/10/1/016012
ISSN/ISBN:		1752-7163 (Electronic) 1752-7155 (Linking)
Abstract:		"The current diagnostic challenge with diagnosing hepatic encephalopathy (HE) is identifying those with minimal HE as opposed to the more clinically apparent covert/overt HE. Rifaximin, is an effective therapy but earlier identification and treatment of HE could prevent liver disease progression and hospitalization. Our pilot study aimed to analyse breath samples of patients with different HE grades, and controls, using a portable electronic (e) nose. 42 patients were enrolled; 22 with HE and 20 controls. Bedside breath samples were captured and analysed using an uvFAIMS machine (portable e-nose). West Haven criteria applied and MELD scores calculated. We classify HE patients from controls with a sensitivity and specificity of 0.88 (0.73-0.95) and 0.68 (0.51-0.81) respectively, AUROC 0.84 (0.75-0.93). Minimal HE was distinguishable from covert/overt HE with sensitivity of 0.79 and specificity of 0.5, AUROC 0.71 (0.57-0.84). This pilot study has highlighted the potential of breathomics to identify VOCs signatures in HE patients for diagnostic purposes. Importantly this was performed utilizing a non-invasive, portable bedside device and holds potential for future early HE diagnosis"
Keywords:		"Adult Aged Aged, 80 and over Breath Tests/instrumentation/*methods Disease Progression *Electronic Nose Exhalation Female Hepatic Encephalopathy/*diagnosis Humans Male Middle Aged Pilot Projects Sensitivity and Specificity Severity of Illness Index Volati;"
Notes:		"MedlineArasaradnam, R P McFarlane, M Ling, K Wurie, S O'Connell, N Nwokolo, C U Bardhan, K D Skinner, J Savage, R S Covington, J A eng England 2016/02/13 J Breath Res. 2016 Feb 11; 10(1):016012. doi: 10.1088/1752-7155/10/1/016012"